| Aβ | Amyloid-β |
| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| ADD | AD with diabetes mellitus |
| ADMET | Absorption, distribution, metabolism, excretion, and toxicity |
| AGEs | Advanced glycation end products |
| AOs | Amine oxidases |
| apoE | Apolipoprotein E |
| APP | Amyloid precursor protein |
| BACE-1 | Beta-secretase 1 |
| BBB | Blood–brain barrier |
| BuChE | Butyrylcholinesterase |
| CAA | Cerebral amyloid angiopathy |
| CAMs | Cell adhesion molecules |
| CNS | Central nervous system |
| DAO | Diamine oxidase |
| DM | Diabetes mellitus |
| DMBA | 7,12-dimethylbenz(alpha)anthracene |
| EAE | Experimental autoimmune encephalomyelitis |
| ECE | Endothelin-converting enzyme |
| eMCAO | Embolic MCAO |
| FAD | Flavin adenine dinucleotide |
| FDA | Food and Drug Administration |
| GLUT | Glucose transporters |
| H2O2 | Hydrogen peroxide |
| HCHWA | Hereditary cerebral hemorrhage with amyloidosis |
| hCMEC/D3 | Human cerebral microvascular endothelial cells |
| HEVs | High endothelial venules |
| HIF-1 | Hypoxia-inducible factor 1 |
| HT | Hemorrhagic transformation |
| HUVEC | Human umbilical vein endothelial cells |
| ICAM-1 | Intracellular adhesion molecule 1 |
| ICH | Intracerebral hemorrhage |
| IDE | Insulin-degrading enzyme |
| IL-1β | Interleukin 1 beta |
| IL-6 | Interleukin 6 |
| IFN- γ | Interferon- γ |
| IRF1 | Interferon regulatory factor 1 |
| JL-72 | 3-(3-hydrazinylpropyl)-1H-indole |
| JNK | c-Jun amino-terminal kinase |
| LOX | Lysyl oxidase |
| LPS | Lipopolysaccharide |
| LRP-1 | Lipoprotein receptor protein-1 |
| LTQ | Lysine tyrosyl quinone |
| MAO | Monoamine oxidase |
| MAPK | Mitogen-activated protein kinase |
| MCAO | Middle cerebral artery occlusion |
| MCI | Mild cognitive impairment |
| MMPs | Matrix metalloproteinases |
| MMSE | Mini-mental state examination |
| MS | Multiple sclerosis |
| MTDL | Multi-target directed-ligand |
| NEP | Neprilysin |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| NVU | Neurovascular unit |
| O2- | Superoxide |
| OGD | Oxygen–glucose deprivation |
| OH· | Hydroxyl radical |
| PAO | Polyamine oxidase |
| PLN | Peripheral lymph node |
| PNAd | Peripheral lymph addressin |
| PrAO | Primary amine oxidase |
| PSEN | Presenilin |
| RAGE | Receptor for advanced glycation end products |
| ROS | Reactive free radicals |
| SAH | Subarachnoid hemorrhage |
| SAMP8 | Senescence accelerated mouse-prone 8 |
| SSAO | Semicarbazide-sensitive amine oxidase |
| STAT3 | Signal transducer and activator of transcription 3 |
| tMCAO | Transient MCAO |
| TNF-α | Tumor necrosis factor α |
| tPA | Tissue plasminogen activator |
| TPQ | Topa-quinone |
| VAP-1 | Vascular adhesion protein-1 |
| VCAM-1 | Vascular cell adhesion protein 1 |
| VEGF | Vascular endothelial growth factor |